As a full-service provider, we have been developing concepts for years for national and international pharmacy delivery for manufacturers of biotechnological preparations. We utilise this know-how and the existing infrastructure to pool the national direct-to-pharmacy business in a targeted way – to the benefit of manufacturers and pharmacies.

Our innovative multi-user concept guarantees our customers twice-daily pharmacy delivery. In addition to logistics processing, the holistic concept also includes multi-channel order taking as well as accounts receivable management. This encompasses all the services throughout the order-to-cash-cycle. The multi-client solution we have developed enables participating pharmaceutical companies to get direct access to pharmacies and facilitates cost-and-service-optimised supply of the pharmacy market. During the entire process, the goods remain the property of the pharmaceutical company.

More information on the concept is available here

The advantages at a glance:

• Lower distribution costs, among other things, through multi-user solutions
• Use of existing, validated distribution structures
• Direct access to pharmacies and their sales data
• Great transparency along the entire distribution chain – all movements of goods and all storage conditions are recorded precisely and without any gaps
  • To reduce security risks and the insertion of counterfeit products
  • To optimize inventory management
  • To optimize delivery service through shorter response times
• Single-source service – efficient and comprehensive processing of all activities by one single service provider

Additional information can be found here.

The Trend toward Direct Business

If one observes the distribution channels of medications, a clear trend has emerged over the past year, away from the traditional route via wholesalers and toward direct delivery to pharmacies by manufacturers.*

The direct-to-pharmacy model, which was originally developed for direct distribution of biotech products with special requirements for transport and storage, has since been extended to mass-produced medications. In Great Britain, well-known companies have already cast aside the traditional distribution model and switched their entire product range to direct distribution.

_{* (Source: Insight Health, press release: Market grows by one billion € – The trend in distribution channels is toward direct business, January 9, 2008)}